secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aura Biosciences, Inc. (AURA)
CIK:        0001501796
Form:       8-K
Filed at:   2026-06-11T20:31:01+00:00
Accession:  0001193125-26-267676
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aura Biosciences stockholders elect directors, ratify auditor at 2026 annual meeting
--------------------------------------------------------------------------------

- David Johnson elected Class II director with 34,542,193 votes for, 6,628,297 withheld.
- Teresa Marie Bitetti elected Class II director with 40,526,332 votes for, 644,158 withheld.
- Ratification of Ernst & Young as auditor passed with 52,752,601 for, 17,348 against, 14,795 abstentions.
- Total shares present or represented: 52,784,744 out of 64,199,778 eligible.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501796/000119312526267676/0001193125-26-267676-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501796/000119312526267676/aura-20260611.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-267676

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer